| Literature DB >> 33937507 |
Ippei Matsuzaki1, Takeshi Ebara2, Mafu Tsunemi3, Yoshifumi Hatta2, Kojiro Yamamoto2, Akemi Baba4, Masashi Hattori1, Masanao Nakamura5, Mitsuhiro Fujishiro5.
Abstract
Background and study aims There has been little evidence assessing the prevalence of musculoskeletal disorders (MSDs) among endoscopists performing recent diagnostic and therapeutic endoscopic procedures requiring prolonged procedural times. We evaluated the prevalence and identified the risk factors for developing MSDs, focusing on procedural time. Methods An electronic survey of endoscopists (n = 213) employed at the Nagoya University Hospital and its affiliated hospitals was developed by a multidisciplinary group. Results Of the 110 endoscopists (51.6 %) who responded to the survey, eighty-seven endoscopists (79.1 %) had experienced endoscopy-related MSDs during the previous 1 year, and 49 endoscopists (44.5 %) had experienced these MSDs during the previous week. Nineteen endoscopists (17.3 %) reported absence from work due to severe MSDs. The most frequent sites of MSDs were neck, low back, and shoulders. Logistic regression analyses showed that longer upper endoscopic submucosal dissection ESD, (odds ratio: 5.7; 95 %CI: 1.3-25.0), lower ESD (odds ratio 4.9; 95 %CI: 1.1-22.0), and lower gastrointestinal treatment (odds ratio: 5.6; 95 %CI: 2.3-13.3) were significantly associated with the development of MSDs in the low back area. Moreover, longer lower ESD (odds ratio: 5.0; 95 % CI: 1.2-20.2) was a risk factor for symptoms in the left shoulder. Conclusion This study suggests a correlation between the volume of therapeutic endoscopic procedures including ESD and the risk of MSDs mainly low back area and left shoulder. Managing monthly total endoscopic time, in light of organizational ergonomics, could contribute to minimizing such risks of endoscopy-related MSDs. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).Entities:
Year: 2021 PMID: 33937507 PMCID: PMC8062226 DOI: 10.1055/a-1352-3850
Source DB: PubMed Journal: Endosc Int Open ISSN: 2196-9736
Fig. 1Participant selection flowchart.
Fig. 2Point/annual-period prevalence of MSDs and incidence of severe MSDs on local body site.
Demographic characteristics of respondents.
| Variables | Those who have any endoscopy-related MSDs currently perceived on neck, shoulders or low back | |||
| Overall (n = 110) | No (n = 73) | Yes (n = 37) |
| |
| Age (%) | 0.93 | |||
Less than 29 | 1 (0.9) | 1 (1.4) | 0 (0) | |
30 to 39 | 61 (55.5) | 40 (54.8) | 21 (56.8) | |
40 to 49 | 21 (19.1) | 14 (19.2) | 7 (18.9) | |
50 to 59 | 23 (20.9) | 16 (21.9) | 7 (18.9) | |
60 or older | 4 (3.6) | 2 (2.7) | 2 (3.6) | |
| Sex(%) | ||||
Male | 98 (89.1) | 62 (84.9) | 36 (97.3) | 0.06 |
Female | 12 (10.9) | 11 (15.1) | 1 (2.7) | |
| BMI (kg/m 2 , mean ± SD) | 23.1 (2.9) | 22.7 ± 2.5 | 23.8 ± 3.3 | 0.05 |
| Seniority (years, %) | ||||
Less than 3 | 6 (5.5) | 4 (5.6) | 2 (5.4) | 0.97 |
4 to 6 | 18 (16.4) | 13 (18.1) | 5 (13.5) | |
7 to 9 | 20 (18.2) | 12 (16.7) | 8 (21.6) | |
10 to 15 | 27 (24.5) | 18 (25.0) | 9 (24.3) | |
≤ 16 | 38 (34.5) | 25 (34.7) | 13 (35.1) | |
Missing | 1 (0.9) | |||
| Dominant hand | ||||
Right | 105 (95.5) | 70 (95.9) | 35 (94.6) | 1.00 |
Left | 5 (4.5) | 3 (4.1) | 2 (5.4) | |
| Specialty (certified fellow of endoscopy) | ||||
No | 27 (24.5) | 19 (26.0) | 8 (21.6) | 0.65 |
Yes | 83 (75.5) | 54 (74.0) | 29 (78.4) | |
| Practice setting (%) | ||||
Academic center | 34 (30.9) | 25 (34.2) | 9 (24.3) | 0.36 |
Large hospital | 35 (31.8) | 20 (27.4) | 15 (40.5) | |
Small hospital | 41 (37.3) | 28 (38.4) | 13 (35.1) | |
| Working hours (h/wk, mean ± SD) | 54.8 (11.4) | 55.3 (10.4) | 53.7 (13.3) | 0.51 |
| Endoscopic work (%, mean ± SD) | 41.6 (21.9) | 40.6 (22.3) | 43.5 (21.1) | 0.51 |
| Type of procedure (min/month) | ||||
Upper GI endoscopy | 380.1 (229.0) | 384.8 (225.8) | 370.9 (238.0) | 0.77 |
Lower GI endoscopy | 565.5 (476.9) | 605.5 (537.1) | 486.5 (319.4) | 0.15 |
Upper ESD | 102.1 (128.5) | 84.7 (93.6) | 136.6 (175.1) | 0.10 |
Upper GI treatment | 53.2 (71.2) | 49.3 (66.3) | 60.8 (80.3) | 0.46 |
Lower ESD | 70.4 (102.6) | 65.6 (95.6) | 79.9 (115.9) | 0.52 |
Lower GI treatment | 448.0 (465.4) | 436.6 (492.0) | 470.3 (413.3) | 0.71 |
Enteroscopy | 93.6 (141.3) | 82.0 (140.3) | 116.4 (142.5) | 0.23 |
ERCP | 206.9 (305.1) | 217.6 (356.6) | 185.7 (163.8) | 0.52 |
EUS | 99.7 (118.6) | 101.5 (126.2) | 96.1 (103.4) | 0.81 |
| Sedentary time (h/d, mean ± SD) | 3.8 (2.7) | 3.7 (2.5) | 3.9 (3.0) | 0.80 |
MSD, musculoskeletal disorders; BMI, body mass index; GI, gastrointestinal; ESD, endoscopic submucosal dissection; ERCP, Endoscopic Retrograde Cholangiopancreatography; EUS, endoscopic ultrasound; Fisher's exact test or Welch's t tests were used to test for differences between groups.
Endoscopy-related work and working postures.
| % | ||||
| n | Standing | Sitting | sit-stand | |
| Upper GI endoscopy | 110 | 108 (98.2) | 2 (1.8) | ― |
| Lower GI endoscopy | 106 | 101 (95.3) | 2 (1.9) | 3 (2.8) |
| Upper ESD | 67 | 64 (95.5) | 3 (4.5) | ― |
| Upper GI treatment | 81 | 81 (100.0) | ― | ― |
| Lower ESD | 52 | 47 (90.4) | 1 (1.9) | 4 (7.7) |
| Lower GI treatment | 105 | 100 (95.2) | 2 (1.9) | 3 (2.9) |
| Enteroscopy | 38 | 38 (100.0) | ― | ― |
| ERCP | 75 | 75 (100.0) | ― | ― |
| EUS | 73 | 73 (100.0) | ― | ― |
GI, gastrointestinal; ESD, endoscopic submucosal dissection; ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasound; ―: not applicable (no answer).
Relative risk of endoscopy-related procedure time affecting local body site on musculoskeletal pain.
| Total time engaged in (min/month) | Pooled adjusted OR (95 %CI) | |||||||
| Neck |
| Right shoulder |
| Left shoulder |
| Low back |
| |
| Upper GI endoscopy | ||||||||
0–150 | 1 | 1 | 1 | 1 | ||||
150–350 | 2.7 (0.4–16.8) | 0.29 | 2.3 (0.4–14.1) | 0.38 | 1.7 (0.2–13.8) | 0.61 | 0.8 (0.1–3.9) | 0.73 |
351–550 | 3.3 (0.5–22.7) | 0.23 | 0.3 (0.0–4.4) | 0.41 | 2.4 (0.3–19.9) | 0.42 | 0.2 (0.0–1.3) | 0.09 |
551 ≤ | 1.8 (0.2–16.5) | 0.59 | 3.2 (0.4–28.7) | 0.29 | 3.9 (0.3–43.4) | 0.27 | 0.4 (0.1–3.1) | 0.40 |
| Lower GI endoscopy | ||||||||
0–250 | 1 | 1 | 1 | 1 | ||||
251–750 | 1.6 (0.5–5.6) | 0.43 | 2.5 (0.6–10.1) | 0.19 | 1.3 (0.3–5.2) | 0.70 | 0.8 (0.4–1.5) | 0.70 |
751 ≤ | 0.9 (0.1–6.1) | 0.95 | 0.6 (0.1–6.9) | 0.70 | 0.7 (0.1–6.5) | 0.73 | 0.5 (0.0–2.3) | 0.41 |
| Upper ESD | ||||||||
none | 1 | 1 | 1 | 1 | ||||
1–90 | 0.5 (0.1–3.2) | 0.51 | 0.4 (0.0–4.0) | 0.47 | 0.8 (0.1–4.9) | 0.82 | 1.2 (0.2–8.3) | 0.82 |
91–180 | 0.8 (0.2–3.0) | 0.74 | 1.1 (0.3–4.4) | 0.94 | 0.3 (0.0–1.5) | 0.13 | 1.3 (0.3–5.6) | 0.73 |
181 ≤ | 1.4 (0.7–3.1) | 0.64 | 1.4 (0.6–3.3) | 0.68 | 0.6 (0.2–1.4) | 0.52 | 5.7 (1.3–25.0) | 0.02 |
| Upper GI treatment | ||||||||
none | 1 | 1 | 1 | 1 | ||||
1–30 | 2.4 (0.4–13.6) | 0.34 | 0.7 (0.1–3.9) | 0.72 | 0.3 (0.1–2.0) | 0.25 | 1.5 (0.3–7.3) | 0.62 |
31–60 | 6.1 (0.9–39.4) | 0.06 | 1.2 (0.5–2.9) | 0.86 | 0.6 (0.1–3.9) | 0.60 | 0.9 (0.3–2.4) | 0.91 |
61 ≤ | 4.1 (0.7–25.1) | 0.12 | 1.2 (1.0–1.3) | 0.85 | 0.6 (0.3–1.4) | 0.56 | 2.7 (1.2–5.9) | 0.21 |
| Lower ESD | ||||||||
none | 1 | 1 | 1 | 1 | ||||
1–90 | 0.7 (0.1–3.9) | 0.68 | 0.4 (0.1–1.3) | 0.45 | 0.7 (0.1–6.7) | 0.73 | 4.9 (1.1–22.0) | 0.04 |
91–180 | 1.3 (0.3–5.0) | 0.72 | 2.0 (0.9–4.4) | 0.36 | 5.0 (1.2–20.2) | 0.04 | 2.2 (1.0–4.8) | 0.30 |
181 ≤ | 1.2 (0.2–7.7) | 0.87 | 1.8 (0.3–12.4) | 0.57 | 1.0 (0.1–11.2) | 0.98 | 4.5 (0.8–24.0) | 0.08 |
| Lower GI treatment | ||||||||
0–75 | 1 | 1 | 1 | 1 | ||||
76–525 | 0.7 (0.2–2.7) | 0.64 | 0.6 (0.1–2.9) | 0.54 | 0.7 (0.1–3.6) | 0.63 | 1.1 (0.3–4.5) | 0.89 |
526 ≤ | 1.0 (0.2–4.0) | 0.99 | 1.3 (0.3–5.4) | 0.75 | 2.0 (0.4–10.1) | 0.39 | 5.6 (2.3–13.3) | 0.05 |
| Enteroscopy | ||||||||
none | 1 | 1 | 1 | 1 | ||||
1–225 | 0.8 (0.2–3.1) | 0.71 | 1.0 (0.4–2.2) | 0.99 | 2.6 (1.2–5.8) | 0.24 | 2.9 (0.7–11.6) | 0.13 |
226 ≤ | 0.6 (0.1–2.9) | 0.47 | 0.8 (0.3–1.9) | 0.78 | 1.8 (0.4–9.3) | 0.47 | 3.9 (1.0–15.8) | 0.06 |
| ERCP | ||||||||
none | 1 | 1 | 1 | 1 | ||||
1–120 | 1.3 (0.2–8.6) | 0.77 | ― | ― | ― | ― | 1.9 (0.3–14.3) | 0.52 |
121–270 | 3.1 (0.9–11.0) | 0.08 | 2.1 (0.5–7.9) | 0.28 | 0.9 (0.2–3.5) | 0.87 | 2.6 (0.6–11.8) | 0.22 |
271 ≤ | 0.4 (0.1–2.5) | 0.33 | 0.2 (0.0–1.3) | 0.10 | 0.4 (0.1–2.1) | 0.28 | 2.6 (0.6–12.5) | 0.23 |
| EUS | ||||||||
none | 1 | 1 | 1 | 1 | ||||
1–90 | 1.6 (0.4–6.3) | 0.52 | 0.4 (0.1–2.4) | 0.31 | 0.2 (0.0–1.2) | 0.08 | 0.9 (0.2–5.0) | 0.95 |
91–180 | 1.8 (0.4–7.3) | 0.42 | 2.3 (0.5–10.3) | 0.28 | 0.5 (0.1–2.5) | 0.41 | 2.6 (0.6–11.2) | 0.19 |
181 ≤ | 0.7 (0.1–4.8) | 0.75 | 0.9 (0.1–6.1) | 0.91 | 0.2 (0.0–0.5) | 0.13 | 1.9 (0.4–9.0) | 0.43 |
GI, gastrointestinal; ESD, endoscopic submucosal dissection; ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasound.
Analyses were adjusted for sex, age, certified fellow of endoscopy, seniority (yrs), working hours (h/wk) and sedentary time (h/d)
―: The value was not calculated due to less frequency.